We are professional Raw Material Manufacturer, with more than 10 years' experience.
Please contact us for more information and detailed quotation
Email: sales12@sgonekbio.com
Phone/WhatsApp/Wechat: +86 13572550462


*The following content is generated by AI and is for reference only.
Branched-Chain Amino Acids (BCAAs) refer to a specific group of three essential amino acids: leucine, isoleucine, and valine. These compounds are characterized by their aliphatic side chains with branching structures, which distinguish them from other amino acids. While often sold as a blended supplement, the "raw material" designation typically implies high-purity individual components or standardized blends used in industrial manufacturing rather than finished consumer goods.
The molecular formulas for the individual BCAAs vary slightly. Leucine is C6H13NO2, Isoleucine is C6H13NO2, and Valine is C5H11NO2. Their respective CAS numbers are 61-91-2 for L-Leucine, 73-32-5 for L-Isoleucine, and 10432-78-3 for L-Valine. In raw material form, these substances appear as white to off-white crystalline powders that are generally odorless and soluble in water. They are chemically stable under standard storage conditions but require protection from moisture and extreme heat to maintain potency.
The primary application of BCAA raw materials lies in the nutritional supplements industry, where they serve as critical building blocks for muscle protein synthesis. Athletes and fitness enthusiasts utilize them extensively to reduce exercise-induced fatigue, accelerate recovery times, and prevent muscle catabolism during intense training regimens. Beyond sports nutrition, these ingredients are vital in clinical nutrition for patients suffering from liver disease, malnutrition, or those recovering from surgery, as they help preserve lean body mass when dietary intake is compromised. Furthermore, BCAA raw materials are incorporated into functional foods, infant formula, and medical food products designed to support metabolic health and immune function. The pharmaceutical sector also utilizes purified BCAAs as excipients or active ingredients in specialized formulations aimed at managing metabolic disorders like maple syrup urine disease. As global demand for performance-enhancing and health-supporting nutraceuticals continues to rise, the production of high-grade BCAA raw materials remains a significant segment of the biotechnology and food processing industries, driven by rigorous quality control standards ensuring purity and bioavailability for diverse end-user applications worldwide.